瞬时弹性成像定义的晚期慢性肝病自然史
结果显示肝硬度值和ALBI评分与静脉曲张及失代偿相关,ALBI评分、年龄、性别和病毒性肝病与代偿期进展为肝细胞癌相关。代偿期未发生失代偿前肝细胞癌5年累积发生率在酒精相关肝病为3.8%、非酒精性脂肪性肝病为1.3%,多数病例预测死亡先于失代偿或肝细胞癌发生。
要点
- 肝硬度值和ALBI评分与静脉曲张及失代偿发生相关。
- ALBI评分、年龄、性别和病毒性肝病与代偿期进展为肝细胞癌相关。
- 代偿期未失代偿前肝细胞癌5年累积发生率酒精相关肝病3.8%、非酒精性脂肪性肝病1.3%。
核心结论
- 肝硬度值、ALBI评分和疾病病因均与大型当代晚期慢性肝病队列的结局相关。
- 电子健康记录数据可用于定义这些患者的临床进展,有助于开展大型临床有效性试验和成本效果分析。
研究设计与样本
- 研究收集2008至2019年瞬时弹性成像数据,纳入肝硬度值>10 kPa的患者。
- 分析电子健康记录中的疾病和操作编码信息,识别失代偿、肝细胞癌和死亡等临床事件。
- 采用多状态模型和灵活参数生存方法描述结局,模型纳入肝硬度值和ALBI评分。
主要发现
- 肝硬度值和ALBI评分与静脉曲张及失代偿的发生相关。
- ALBI评分、年龄、性别和病毒性肝病与从代偿状态进展为肝细胞癌相关。
- 代偿期未发生失代偿前肝细胞癌5年累积发生率在酒精相关肝病为3.8%,在非酒精性脂肪性肝病为1.3%。
- 多数病例预测死亡先于失代偿或肝细胞癌发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The clinical course of cirrhosis does not follow a predictable trajectory. Transient elastography (TE) is commonly used in clinical practice to diagnose liver fibrosis and increasingly to risk stratify patients. The aim of this study was to assess the natural history of advanced chronic liver disease (ACLD) defined by TE using electronic health record (EHR) data in a multistate framework. METHODS: TE data were collected between 2008 and 2019. Patients with a liver stiffness measurement (LSM) >10 kPa were included. Disease and procedure code information held in EHR was analyzed. Clinical events including decompensation, hepatocellular carcinoma (HCC), and death were identified. Outcomes were described in a multistate model using flexible parametric survival methods including LSM and the albumin bilirubin (ALBI) score. RESULTS: Three thousand and twenty eight patients were included. Median follow up was 3.1 years. LSM and ALBI were associated with the development of varices and decompensation, and ALBI, age, sex, and viral liver disease were associated with the development of HCC from the compensated state. The cumulative incidence of HCC before decompensation was low for patients with alcohol-related liver disease (3.8%) and nonalcoholic fatty liver disease (1.3%) at 5 years after TE. Importantly, death was predicted to occur before decompensation or HCC in most cases. CONCLUSIONS: Liver stiffness, ALBI score, and disease etiology are each associated with outcomes in a large contemporary cohort with ACLD. EHR data can be used to define clinical progression in these patients, facilitating large clinical effectiveness trials and cost-effectiveness analyses.
引用
- Shearer JE, Jones R, Parker R, et al. The Natural History of Advanced Chronic Liver Disease Defined by Transient Elastography. Clin Gastroenterol Hepatol. 2022. PMID: 35337981. doi:10.1016/j.cgh.2022.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。